Background-The pathophysiological basis for the association between metabolic syndrome (MetS) and coronary artery disease is not well understood. We sought to characterize coronary plaques in patients with MetS by using optical coherence tomography. Methods and Results-We identified 451 coronary plaques from 171 subjects who underwent optical coherence tomographic imaging in 3 coronary arteries. Subjects were divided into 3 groups: diabetes mellitus (DM, n=77), MetS (n=35), and a control group (C group, n=59) without DM or MetS. Optical coherence tomographic analysis included the presence of lipid-rich plaque, maximum lipid arc, lipid-core length, lipid index (LI), fibrous cap thickness, and thin-cap fibroatheroma. We defined LI as mean lipid arc multiplied by lipid-core length. Lipid-core length and LI were significantly greater in DM and MetS than in C group (lipid-core length: 7.7±4.0 and 7.0±3.8 versus 5.5±2.4 mm; P<0.001 and P=0.012, and LI: 1164±716 and 1086±693 versus 796±417 mm; P<0.001 and P=0.008). Maximum lipid arc was significantly greater in DM than in C group, whereas no significant difference was observed between MetS and C group (196±45°, 187±42° versus 176±52°; P=0.002 and P=0.182). Fibrous cap thickness and thin-cap fibroatheroma showed no significant difference among the 3 groups. In multivariate analysis, DM and MetS were independently associated with LI, whereas only acute coronary syndrome was the independent predictor for thin-cap fibroatheroma. Conclusions-Compared with control subjects, coronary plaques in MetS contain larger lipid. However, the MetS criteria used in this study could not distinguish the vulnerable features such as thin-cap fibroatheroma, suggesting the necessity of complementary information to identify patients at high risk for cardiovascular events. (Circ Cardiovasc Imaging. 2013;6:665-673.) The online-only Data Supplement is available at http://circimaging.ahajournals.org/lookup/suppl/
M etabolic syndrome (MetS) is defined by a set of inter-related clinical features that includes obesity, hypertension, dyslipidemia, and hyperglycemia. 1, 2 The association and clustering of these factors have been extensively studied, and previous studies have revealed an association between MetS and a higher incidence of cardiovascular events. 3, 4 Despite many clinical and epidemiological studies that have reported an elevated risk for cardiovascular disease in patients with MetS, unique coronary plaque characteristics in patients with MetS have not been identified. A further understanding of the pathophysiology of coronary artery atherosclerosis in MetS may enable us to better understand and treat ischemic heart disease in this population.
Optical coherence tomography (OCT) is an intravascular imaging technique that allows for high resolution visualization of the coronary arteries. 5, 6 OCT can provide detailed structural information on intracoronary pathology, including atherosclerotic plaques in vivo. As such, it provides a unique platform to evaluate the association between MetS and coronary artery pathology. The purpose of this study was to determine the coronary plaque characteristics of subjects with MetS in comparison with subjects who are diabetic and normoglycemic by using OCT.
Methods

Study Population
The Massachusetts General Hospital OCT Registry is an ongoing multicenter registry of patients undergoing OCT of the coronary arteries and includes 20 sites across 6 countries. Patient selection for the present study is summarized in Figure 1 . In a total of 1406 subjects who were enrolled in the registry between August 2010 and May 2012, a total of 255 subjects underwent OCT imaging of all 3 major epicardial coronary arteries during the same procedure. Only patients with complete information on clinical history, laboratory data, and physical status and those with sufficient image quality for all 3 vessels were selected. Therefore, 198 subjects with complete demographic data and sufficient 3-vessel OCT images were identified. From this cohort, we selected the patients who had nonculprit or nontarget coronary plaques with area stenosis >50% as measured by OCT. Patients without any nonculprit plaques were also excluded. In-stent restenosis and lesions that required balloon angioplasty before OCT imaging were excluded. The final data set comprised 451 plaques from 171 subjects. Subjects were divided into 3 groups: those with diabetes mellitus (DM group, 206 plaques in 77 subjects), non-DM subjects with MetS (MetS group, 102 plaques in 35 subjects), and subjects without DM or MetS (control group [C] group, 143 plaques in 59 subjects; Figure 2 ). The registry was approved by the institutional review board in each participating site, and all subjects provided informed consent.
MetS Factors
DM was diagnosed in the participating site based on the American Diabetes Association definition if the patient had ≥1 of the following criteria: fasting glucose ≥126 mg/dL, 2-hour plasma glucose level ≥200 mg/dL in the oral glucose tolerance test, classic symptom with casual plasma glucose level ≥200 mg/dL or A1c ≥6.5%. 7 Patients who were taking hypoglycemic agents were also diagnosed as DM in the present study. MetS was based on the definition established in the Joint Scientific Statement as a subject with ≥3 of the following: waist circumference ≥102 cm for men or ≥88 cm for women; triglycerides ≥150 mg/dL; high-density lipoprotein cholesterol ≤40 mg/dL; blood pressure ≥135/85 mm Hg; and fasting blood glucose level ≥100 mg/dL. 1 In the present study, we used body mass index (BMI) as a substitute for waist circumference because data on waist circumference were not obtained in our registry. We used a BMI cutoff of 29.4 kg/m 2 for men and 26.7 kg/m 2 for women as previously reported. 8, 9 In addition, history of hypertension was used as an alternative for the presence of documented blood pressure ≥135/85 mm Hg because the majority of subjects had been treated with antihypertensive agents. Therefore, MetS was defined by the presence of 3 or more MetS factors of the following: (1) BMI ≥29.4 kg/m 2 for men and 26.7 kg/m 2 for women; (2) triglycerides ≥150 mg/dL; (3) high-density lipoprotein cholesterol ≤40 mg/dL; (4) history of hypertension; and (5) fasting blood glucose level ≥100 mg/dL, as shown in Figure 2 .
Coronary Angiography
Coronary angiograms were analyzed by offline quantitative coronary angiography (CAAS version 5.10.1, Pie Medical Imaging BV. Maastricht, The Netherlands). Reference diameter, minimum lumen diameter, diameter stenosis, and lesion length were measured.
OCT Image Acquisition
Either the time-domain (M2/M3 Cardiology Imaging System, LightLab Imaging, Inc, Westford, MA) or frequency-domain OCT system (C7-XR OCT Intravascular Imaging System, St. Jude Medical, St. Paul, MN) was used in the study. The intracoronary OCT imaging technique has been previously described. 10 In brief, with the M2/M3 system, an occlusion balloon (Helios, LightLab Imaging Inc, From the subjects who were enrolled in the Massachusetts General Hospital optical coherence tomography (OCT) registry, we selected those who underwent OCT investigations for 3 coronary vessels in the same procedure. After exclusion of the subjects who had insufficient image quality and incomplete demographic data, a total of 198 subjects were analyzed, and 451 plaques from 171 subjects were identified in the final data set. Westford, MA) is advanced proximal to the lesion and inflated ≤0.4 to 0.6 atm during image acquisition. The imaging wire is automatically pulled back from distal to proximal at 1.0 to 3.0 mm/s, and saline is continuously infused from the tip of occlusion balloon. With the C7 system, a 2.7 F OCT imaging catheter (Dragonfly, LightLab Imaging Inc, Westford, MA) is advanced distal to the lesion, and automatic pullback is started as soon as the blood is cleared. All images were digitally stored, deidentified, and submitted to the Massachusetts General Hospital (Boston, MA) for analysis.
OCT Image Analysis
Each plaque was classified as lipid-rich or fibrous plaque. We defined lipid as a diffusely bordered signal-poor region with signal attenuation by the overlying signal-rich layer, and lipid-rich plaque as a plaque with lipid >90°. 5 For lipid-rich plaque, we determined lipid arc, lipid-core length, thinnest fibrous cap thickness (FCT), as well as the presence of thin-cap fibroatheroma (TCFA), macrophage accumulation, cholesterol crystal, and microvessels ( Figure 3 ). Lipid arc was measured every 1 mm within a lipid-rich plaque, and mean and maximum values were recorded ( Figure 3A ). Lipid-core length was defined as the length of plaque with >90° of lipid and measured on the longitudinal view ( Figure 3B ). We also calculated the lipid index, which was defined as the mean lipid arc multiplied by lipid-core length. 10 The thinnest FCT of a lipid-rich plaque was measured at the thinnest part 3×, and the values were then averaged ( Figure 3C ). TCFA was defined as a lipid-rich plaque with a maximum lipid arc >90° and FCT ≤65 µm. 11 Macrophage accumulation on the OCT images was defined as increased signal intensity within the plaque, accompanied by heterogeneous backward shadows ( Figure 3D ). 12, 13 Cholesterol crystals were characterized as thin and linear regions of high intensity existing beside lipid core. 14 Microvessels were defined as small vesicular or tubular structures with diameters 50 to 300 μm and differentiated from any other branch ( Figure 3E ). 15 Plaque disruption was defined as a discontinuity of the fibrous cap with communication between the vessel lumen and the cavity. Calcification was also recorded when an area with low backscatter and a sharp border was identified inside a plaque. 16 OCT images were analyzed by 2 investigators who were blinded to the subject's information. When there was discordance between the readers, a consensus reading was obtained from a third independent investigator.
Statistical Analysis
Categorical data were presented as counts and proportions and were compared using either a χ 2 test or Fisher exact test, depending on the data. Continuous measurements were presented as mean±SD and analyzed with the ANOVA and Bonferroni correction for multiple comparisons. For comparisons between groups, analysis was performed by means of the generalized estimating equations approach to take into account the within-subject correlation attributable to multiple plaques analyzed within a single subject. Multiple linear regression and logistic regression analyses were performed to assess the independent predictors for lipid index and the presence of TCFA. Multiple regression models included the parameters that showed statistical significance with the P<0.05 in the univariate analysis. The correlation between OCT parameters and the number of MetS factors was analyzed with Spearman rank correlation coefficients. Interobserver and intraobserver reliabilities were estimated by means of κ coefficient for binary outcomes and intraclass correlation coefficient for continuous measurements. All statistical analyses were performed with SPSS version 17.0. A P<0.05 was considered statistically significant.
Results
Clinical Characteristics
Patient characteristics are summarized in Table 1 . As expected, there were significant differences between the 3 groups. A history of hypertension was significantly more frequent in the DM and MetS groups than in the C group. Body weight, BMI, and triglyceride level were significantly greater in the MetS group than in the C group. High-density lipoprotein cholesterol was significantly lower in MetS than in the C group. Fasting blood glucose level was significantly different among the 3 groups, and the highest in the DM group. The number 
Three-Vessel OCT Imaging and Angiographic Findings
The mean total length of coronary arteries imaged by OCT was 221±45 mm; 94±25 mm in the right coronary artery, 72±23 mm in the left anterodescending coronary artery, and 55±18 mm in the circumflex. There was no significant difference in total imaged length among the DM, MetS, and C groups (205±41, 215±42, and 215±43 mm; P=0.302). Plaque location and angiographic data are shown in Table 2 . There was no significant difference in plaque location and angiographic data among the 3 groups.
OCT Findings
The OCT findings from each group are summarized in Table 3 . There were no significant differences in the number of plaques per subject and the prevalence of lipid-rich plaque among the 3 groups. Maximum lipid arc, lipid-core length, and lipid index were significantly greater in the DM group than those in the C group. Subjects with MetS showed a significantly longer lipid length and a greater lipid index as compared with those in C group. No significant difference was observed between DM and MetS in maximum lipid arc, lipidcore length, and lipid index. FCT only showed a trend toward smaller value in the DM and MetS groups as compared with C group. There were no significant differences in the prevalence and number of TCFA across the 3 groups. Calcification was more frequent in plaques of subjects with DM than in those of subjects with MetS. The prevalence of other microstructures, such as macrophage accumulation, microvessels, or cholesterol crystals, was not statistically different among the 3 groups.
Correlation Between the Number of MetS Factors and Lipid-Rich Plaque
Maximum lipid arc, lipid-core length, and lipid index increased linearly as the number of MetS factors increased.
Although the linear trends with positive slopes were statistically significant, their magnitudes of the explained variations by the number of MetS factors were not large (maximum lipid arc: ρ=0.182; P=0.005, lipid-core length: ρ=0.202; P=0.002, and lipid index: ρ=0.225; P<0.001). No significant correlation was observed for FCT (ρ=−0.116; P=0.075; Figure 4 ).
Multiple Regression Analyses for Lipid Index and TCFA
Multiple linear regression and logistic regression analyses were performed to assess the determinants of lipid index and the presence of TCFA. As shown in Table 4 , DM and MetS were independently associated with greater lipid index. However, only ACS presentation was independently associated with TCFA although DM and MetS did not show significant trend.
Observer Variabilities
The estimated interobserver and intraobserver κ coefficients were 0.90 and 0.93 for the presence of lipid-rich plaque and 0.84 and 0.84 for the presence of microvessels. Intraclass correlations were 0.87 and 0.97 for mean lipid arc and 0.86 and 0.90 for lipid-core length, respectively.
Discussion
To our knowledge, this is the first OCT study investigating in detail the plaque characteristics of patients with MetS in comparison with patients with DM and those without DM or MetS. Our OCT data demonstrated that (1) subjects with MetS had larger lipid burden compared with those without MetS, (2) frequency of TCFA did not differ among subjects with DM, those with MetS, and those without DM or MetS, (3) the prevalence of microstructure, such as macrophage accumulation, microvessels, and cholesterol crystals, did not show any significant differences among the 3 groups.
Lipid-Rich Plaque
One of the important components of rupture-prone plaque is a large necrotic core, which may physically increase the tension of fibrous cap covering the lipid core and lead to disruption. 17 Several pathological and virtual histology-intravascular ultrasound studies have shown that coronary plaques in nonculprit lesions of patients with DM had larger plaque burdens and a larger necrotic core than in those of the patients without DM, 11, 18, 19 which is consistent with our data. However, a recent OCT study by Niccoli et al 20 demonstrated smaller lipid arc, larger calcium, and comparable FCT in the culprit lesions of DM at the first ACS manifestations as compared with non-DM patients. Their results suggest that even small amount of lipid may be able to cause an acute coronary syndrome in patients with DM, which supports the importance of aggressive lipidlowering therapy in patients with DM for primary or secondary prevention. Although the pathophysiological features of atherosclerosis in DM have been substantially explored, those in MetS have not been elucidated. The present study demonstrates a greater amount of lipid in nonculprit/nontarget plaques in subjects with MetS as compared with plaques in subjects without MetS or DM. These results support the previous virtual histology-intravascular ultrasound studies reporting a greater percentage of necrotic core in patients with MetS than in those without MetS. 19, 21 
TCFA and FCT
Although the variability and heterogeneity of FCT at the time of plaque rupture have been reported in vivo, 22, 23 thin fibrous cap (<65 µm) defined by pathological study 11 has been recognized as the most critical feature of vulnerable plaque. However, there was no significant trend in the frequency of TCFA and FCT across the 3 groups in the present study, whereas the extent of lipid expressed by lipid index was greater in DM and MetS groups. A previous virtual histology-intravascular ultrasound study showed a high prevalence of TCFA in patients with DM and MetS. 19 However, a larger cohort of subanalysis in PROSPECT trial showed insignificant association of MetS with the presence of virtual histology-derived TCFA. 21 These inconsistent results may reflect the ambiguous effect of MetS on plaque instability. In a previous intravascular ultrasound and OCT study, Takarada et al 24 reported that FCT was significantly correlated with high-sensitive C reactive protein rather than with lipid profiles, whereas atheroma volume showed a significant correlation only with cholesterol profiles. Their results suggested different mechanisms of regulation between lipid volume and FCT. Although several formal definitions of MetS have been proposed so far, the traditional definition that served as the basis for the present study does not include biomarkers of inflammation. These markers are likely to correlate more strongly with structural features of plaque vulnerability, including the development of thin fibrous cap. Indeed, only the independent predictor for TCFA in the present study was the clinical presentation of ACS, which is related to systemic inflammation. Previous studies demonstrated that stratification by inflammatory status indicated by high-sensitive C reactive protein adds prognostic information to the diagnosis of MetS. 8, 25 The lack of a significant association between MetS and FCT or TCFA in the present study likely results from the incompleteness of traditional MetS criteria. Additional information including inflammatory markers might be helpful for better differentiation of plaque vulnerability in addition to the diagnosis of MetS and DM.
Number of Factors and Lipid
Although each factor of MetS is known separately to be a cardiovascular risk factor, it is generally accepted that the combination of those components and their inter-relationship lead to the progression of atherosclerosis. 26 However, some studies have cast doubt on the association between MetS and cardiovascular events. 27, 28 In the present study, multiple linear regression analysis demonstrated that MetS is an independent predictor for large amount of lipid. However, caution should be exercised when interpreting these data. As shown in Figure 4 , correlations between the number of MetS factors and OCT findings including lipid index and FCT were mild, and significant overlaps were found across the number of MetS factors (Figure 4) . In other words, MetS does not provide additive predictive values beyond its individual components. Furthermore, these OCT parameters are just surrogates of the extent of lipid, which may not be necessarily associated with the risk of future cardiovascular events.
Microstructures Observed in OCT
OCT is a unique in vivo intravascular imaging modality that allows for visualization of microstructures such as macrophage accumulation, microvessels, and cholesterol crystals. 12, 13, 29, 30 These microscopic changes are affected by multiple factors such as systemic inflammation, hypoxia, oxidative stress, and statin therapy. 31, 32 Although DM and MetS were expected to have impacts on these factors, our data showed only a weak trend toward more frequent microvessels in DM and MetS groups (P=0.091). The statin use and low-density lipoprotein cholesterol levels were not different among the groups at the time of OCT imaging (P=0.496 and P=0.545, respectively). Unfortunately, we do not have information on the previous low-density lipoprotein cholesterol levels and duration of statin therapy. A prospective systemic study may elucidate this relationship.
Calcification in DM and MetS
The present study showed higher prevalence of calcification in plaques of subjects with DM as compared with those of subjects with MetS in nonculprit or nontarget lesions. Our data are consistent with a previous computed tomographic study that revealed an intermediate association between MetS and Agatston score by multidetector computed tomography, whereas patients with DM showed remarkable association with greater calcium scores regardless of MetS. 33 A recent OCT study also demonstrated more frequent superficial calcium and larger calcium amount in the culprit vessels of ACS in patients with DM as compared with non-DM patients, 20 which is also consistent with our data. One of the advantages of OCT imaging for the evaluation of calcium is the potential to detect a small calcification in the plaque and to determine the morphological characteristics of calcium such as nodular calcium. As of now, the nature and process of coronary calcification have not been well studied in vivo. Further study with use of serial OCT imaging would be warranted to understand the pathophysiology of coronary calcification.
Limitations
The present study has several limitations. First, this study is a retrospective observational study from a registry database; therefore, selection bias may have influenced the results. In addition, we selected the patients who underwent 3-vessel OCT investigation to diminish the bias from the studied vessel. However, there still might have been a selection bias as shown in Tables I and II in the online-only Data Supplement. Second, our OCT registry data did not include information on waist circumference, so we used BMI as a substitute for the determination of obesity. Moreover, the presence of high blood pressure was substituted with the history of hypertension. Our modified definition of MetS may have affected the results. Third, we included only plaques with area stenosis >50% as indicated by OCT. Although this criterion is accepted in the consensus documents, 34 it is the criteria for a stenosis rather than the definition of a plaque. Early stages of atherosclerosis with expansive remodeling may have been excluded. Fourth, no inflammatory markers such as high-sensitive C reactive protein were assessed in this study. Fifth, the duration and type of DM were not available in the registry, which might have influenced plaque characteristics. Sixth, we used lipid index calculated from OCT parameters. However, this value is a surrogate of the necrotic core burden. Finally, a lack of longitudinal follow-up data did not allow for the assessment of the clinical impact of OCT findings on the future events.
Conclusions
Plaques in subjects with MetS contain larger lipid content than those in subjects without MetS, whereas FCT was not significantly associated with the diagnosis of MetS.
